David H. Lynch
Geen lopende functies
Profiel
David H.
Lynch served as the Chief Executive Officer & Director at ApoVax, Inc. He also worked as a Director-Collaborative Research at Amnis Corp.
and held Principal positions at Amgen, Inc. and Immunex Corp.
Lynch was also a Principal at the Canadian Network for Vaccines & Immunotherapeutics.
He earned a doctorate degree from the University of Utah in 1979.
Eerdere bekende functies van David H. Lynch
| Bedrijven | Functie | Einde |
|---|---|---|
ApoVax, Inc.
 ApoVax, Inc. Medical/Nursing ServicesHealth Services ApoVax, Inc. developed immunotherapies and therapeutic vaccines. It was a biotechnology company that developed novel immunotherapies, which are treatments based on regulating the host immune system to fight disease. The firm was a scientific foundation that built on two platform technologies that are used to modulate the immune system-ProtEx and ApoVax. The company was founded by Haval Shirwan in 2001 and was headquartered in Louisville, KY. | Algemeen Directeur | - |
| Canadian Network for Vaccines & Immunotherapeutics | Corporate Officer/Principal | - |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Amnis Corp.
 Amnis Corp. BiotechnologyHealth Technology Amnis Corp. provides cell imaging and instrument development, manufacturing and marketing services. The Company's ImageStreamX and FlowSight imaging flow cytometers combine the speed and sensitivity of flow cytometry with the power of digital microscopy serving a broad spectrum of Life Sciences research market needs. The company was founded by David A. Basiji, William E. Ortyn and Harold H. Kawaguchi in 1999 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Opleiding van David H. Lynch
| University of Utah | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
Amnis Corp.
Amnis Corp. BiotechnologyHealth Technology Amnis Corp. provides cell imaging and instrument development, manufacturing and marketing services. The Company's ImageStreamX and FlowSight imaging flow cytometers combine the speed and sensitivity of flow cytometry with the power of digital microscopy serving a broad spectrum of Life Sciences research market needs. The company was founded by David A. Basiji, William E. Ortyn and Harold H. Kawaguchi in 1999 and is headquartered in Seattle, WA. | Health Technology |
ApoVax, Inc.
ApoVax, Inc. Medical/Nursing ServicesHealth Services ApoVax, Inc. developed immunotherapies and therapeutic vaccines. It was a biotechnology company that developed novel immunotherapies, which are treatments based on regulating the host immune system to fight disease. The firm was a scientific foundation that built on two platform technologies that are used to modulate the immune system-ProtEx and ApoVax. The company was founded by Haval Shirwan in 2001 and was headquartered in Louisville, KY. | Health Services |
| Canadian Network for Vaccines & Immunotherapeutics |
